ライフサイエンスコーパス: neurological complication

1 No patient suffered a postoperative neurological complication.

2 acrolimus without recurrence of the original neurological complication.

3 ing (n=1) without recurrence of the original neurological complication.

4 This emerging infection is associated with neurological complication.

5 sociated with severe respiratory illness and neurological complication.

6 aneurysms following atrial myxoma is a rare neurological complication.

7 t against HIV-1 infection and HIV-associated neurological complications.

8 fic therapeutic approach may avoid long-term neurological complications.

9 reatment reduced (by 33% to 75%) the risk of neurological complications.

10 MO implantation may reduce the perioperative neurological complications.

11 ze the treatment of patients presenting with neurological complications.

12 preeclampsia that involves life-threatening neurological complications.

13 es in patients with AS could prevent serious neurological complications.

14 ng-term follow up is required to detect late neurological complications.

15 ngitis and to delineate the full spectrum of neurological complications.

16 -based data to guide the management of these neurological complications.

17 liver dysfunction, kidney damage, as well as neurological complications.

18 hanges in brain activity caused by secondary neurological complications.

19 from a subset of breast cancer patients with neurological complications.

20 ferentially in the subset experiencing acute neurological complications.

21 des were independent risk factors for severe neurological complications.

22 scular syndrome with predominantly renal and neurological complications.

23 ecause defects can lead to hematological and neurological complications.

24 ive individuals who had died of AIDS and had neurological complications.

25 r macrophages in the brains of patients with neurological complications.

26 to bloody diarrhea, acute renal failure, and neurological complications.

27 with encephalitis, and 4 with postinfectious neurological complications.

28 eased risk of acute renal failure and severe neurological complications.

29 re significantly higher in participants with neurological complications.

30 t role in the pathogenesis of HIV-associated neurological complications.

31 associated Guillain-Barre syndrome and other neurological complications.

32 avirus disease 2019 (COVID-19) patients with neurological complications.

33 ociation with severe respiratory disease and neurological complications.

34 porting their use for managing typhoid fever neurological complications.

35 ne flavivirus, is associated with congenital neurological complications.

36 ypes of LSDs, including Gaucher disease with neurological complications.

37 f latent VZV in humans can result in serious neurological complications.

38 ome, and fetal microcephaly as well as other neurological complications.

39 irth, or severe congenital abnormalities and neurological complications.

40 nctive pharmacology have an inherent risk of neurological complications.

41 llain-Barre syndrome(2,3) as ZIKV-associated neurological complications.

42 t human brain and is associated with serious neurological complications.

43 patients and causes frequent thrombotic and neurological complications.

44 ions are important for relieving VZV related neurological complications.

45 ferentiated between patients with or without neurological complications.

46 feet, and throats to infections with severe neurological complications.

47 en that causes hand, foot, mouth disease and neurological complications.

48 umab), 10 (2.9%) developed subacute onset of neurological complications.

49 ly associated with an increased incidence of neurological complications.

50 ul blisters around their mouths and hands to neurological complications.

51 disease (HFMD) and are often associated with neurological complications.

52 fluid features of 31 COVID-19 patients with neurological complications.

53 cell transplantations with a development of neurological complications.

54 %]; P=0.03), while a significant increase in neurological complication (0.17% [95% CI, 0.06%-0.28%];

55 .53%), respiratory complications (1.3%), and neurological complications (1.02%).

56 1.3%), ophthalmic complications (340, 8.3%), neurological complications (665, 16.2%), peripheral circ

57 Whereas 11.6% of patients had neurological complications, 88.4% displayed mild disease

58 12 deficiency, such as macrocytic anemia and neurological complications affecting sensory and motor f

59 o assess the role of serum bile acids in the neurological complications after acute liver failure.

60 Pa(CO(2)) was independently associated with neurological complications after controlling for previou

61 Neurological complications after OLTX disorders that occ

62 Neurological complications after orthotopic liver transp

63 Neurological complications after transcatheter aortic va

64 Chronic pain is a prevalent neurological complication among individuals living with

65 developed to analyze variables predictive of neurological complications and associated mortality.

66 foot, and mouth disease (HFMD), with severe neurological complications and cardio-respiratory compro

67 tively antiretroviral therapy on HIV-related neurological complications and changes in treatment stra

68 In addition, neurological complications and coinfection with bacteria

69 , ranging from mild rash and fever to severe neurological complications and congenital malformations.

70 diseases and, in rare instances, can lead to neurological complications and death.

71 sed only on parasite killing fail to prevent neurological complications and deaths associated with se

72 the divergent pathogenesis of TBM-associated neurological complications and deaths, therapeutic strat

73 ntracranial aneurysms (VSIAs) may cause many neurological complications and even death.

74 Severe infection with EV71 can lead to neurological complications and even death.

75 , especially in very young children, causing neurological complications and even death.

76 Zika virus has been associated with serious neurological complications and fetal abnormalities.

77 has been associated with a rise in cases of neurological complications and fetal central nervous sys

78 Susceptible animals showed greater neurological complications and had higher levels of bloo

79 th the WHO, has reviewed reports of COVID-19 neurological complications and harmonised clinical measu

80 us outbreaks, including its association with neurological complications and heightened disease severi

81 th of stay, teaching status of the hospital, neurological complications and infectious complications

82 damental to achieve proper management, avoid neurological complications and lead to a good prognosis.

83 insights into the mechanisms of ZIKV-induced neurological complications and potential targets for the

84 ch was associated with considerable rates of neurological complications and procedure-related complic

85 ent approaches, including treatment of acute neurological complications and the use of immune suppres

86 in latent HIV-1 infection, HIV-1 associated neurological complication, and other HIV-1 comorbidities

87 general infections, pulmonary complications, neurological complications, and admission to the intensi

88 omes, including birth defects, microcephaly, neurological complications, and even spontaneous abortio

89 Neurological complications are an important concern in p

90 Neurological complications are an increasingly recognize

91 in the literature, we show that extra-ocular neurological complications are common in adults with gen

92 ding 60 new cases, we show that extra-ocular neurological complications are common in OPA1 disease, a

93 Neurological complications are common in patients with C

94 Neurological complications are common in sickle cell dis

95 env) in the brain tissue of individuals with neurological complications are frequently highly macroph

96 Diagnosis and treatment of neurological complications are important in maintaining

97 ansfusion, venous thromboembolic, renal, and neurological complications, as the best solution for par

98 epticemia, toxemia, and meningitis, the main neurological complication associated with high mortality

99 1 infection of the CNS may contribute to the neurological complications associated with AIDS dementia

100 spectrum, and optimum treatment approach to neurological complications associated with anti-PD-1 the

101 Emerging reports of rare neurological complications associated with COVID-19 infe

102 id concentrations may reduce the severity of neurological complications associated with liver failure

103 ize that such risks are typically dwarfed by neurological complications associated with natural infec

104 of ADE in the development of congenital and neurological complications associated with ZIKV infectio

105 uced ability to self-care at discharge, with neurological complications being associated with the wor

106 only heightens the risk of stroke and other neurological complications but also increases susceptibi

107 ribed elsewhere who have MYO5A mutations and neurological complications but no immunologic defects ma

108 Neurological complications by 3 months were significantl

109 Neurological complications by 3 months were significantl

110 Neurological complications can be categorised into dengu

111 Cerebral malaria (CM) is a severe neurological complication caused by Plasmodium falciparu

112 Awareness of the expanding spectrum of neurological complications caused by VZV reactivation wi

113 (CO(2)) (>50%) had an increased incidence of neurological complications compared with those with a sm

114 Analyses of neurological manifestations and neurological complications considered unadjusted prevale

115 New acute and chronic neurological complications continue to be reported.

116 These non-classical neurological complications could be more prevalent becau

117 The primary outcome was the occurrence of neurological complications, defined as seizures, ischemi

118 Neurological complications developed in 4.8% and 4.5%, r

119 Patients with neurological complications directly attributable to meta

120 Neurological complications due to chikungunya virus (CHI

121 Neurological complications due to the HIV itself became

122 n, early diagnosis, and proper management of neurological complications during the acute phase of str

123 Optimal management regimens of neurological complications (eg, hydrocephalus and parado

124 oportion of patients with IE and preexisting neurological complications either undergo delayed surger

125 tment can lead to cerebral edema and serious neurological complications, especially if the decrease i

126 e conditions may be followed by a variety of neurological complications, especially in immunocompromi

127 Neurological complications, especially stroke, have long

128 er recipients receiving CyA and experiencing neurological complications, fever of unknown origin, sei

129 Despite this, rates of neurological complications following acute SARS-CoV-2 in

130 monitored for a wider spectrum of potential neurological complications following DENV infection.

131 addition, we noted a trend toward heightened neurological complications following second wave influen

132 ied 18 children with 2009 H1N1 influenza and neurological complications from first and second wave ac

133 equently called upon to assess patients with neurological complications from the procedure.

134 Overall mortality was 30%, and neurological complications had a negative impact on outc

135 alaria induces severe but usually reversible neurological complications has not been elucidated.

136 , diverse cardiological, systemic as well as neurological complications have been reported.

137 Neurological complications have emerged as a significant

138 d the virus to the cases of microcephaly and neurological complications have revealed the need for co

139 However, neurological complications, hospitalization, and even de

140 In two patients with secondary neurological complications, ICE demonstrated prominent a

141 Delirium is a common neurological complication in patients with advanced hear

142 Acute ischemic stroke (AIS) is a known neurological complication in patients with respiratory s

143 Hepatic encephalopathy (HE) is a major neurological complication in patients with severe liver

144 hemorrhage (GM-IVH) is the most devastating neurological complication in premature infants.

145 e requiring hemodialysis developed in 50.0%, neurological complications in 16.0%, and hydrostatic pul

146 event after primary infection, resulting in neurological complications in a significant number of in

147 nt with dexamethasone, remdesivir or both on neurological complications in acute coronavirus diease 2

148 r, the pathogenic mechanisms of ZIKV-induced neurological complications in adults and congenital malf

149 , especially the first description of severe neurological complications in adults and the retrospecti

150 ause congenital deformities in the fetus and neurological complications in adults.

151 is a major cause of lifelong disability and neurological complications in affected infants.

152 Neurological complications in AIDS occur when this contr

153 -19 was associated with a lower frequency of neurological complications in an additive manner, such t

154 diabetes insipidus, deafness, urological and neurological complications in combination or in isolatio

155 atients suffered more frequently from severe neurological complications in comparison to all control

156 be a promising strategy to prevent or treat neurological complications in COVID-19 patients.

157 mplicated in the development of vascular and neurological complications in diabetes.

158 ates for treating ZIKV infection and related neurological complications in fetal and adult patients.

159 a virus was established as a cause of severe neurological complications in fetuses, neonates, and adu

160 ral neuropathies have become the most common neurological complications in HIV infection.

161 s potential underpinnings of ZIKV-associated neurological complications in humans.

162 ality may contribute to the understanding of neurological complications in malaria.

163 rier to viral eradication and contributor to neurological complications in patients despite antiretro

164 rvous system (CNS) gives rise to many of the neurological complications in patients with AIDS.

165 er transplant (LT) increases risk of post-LT neurological complications in patients with decompensate

166 of this study was to assess the incidence of neurological complications in patients with infective en

167 is associated with an increased incidence of neurological complications in patients with respiratory

168 s were related primarily to a higher risk of neurological complications in PVD patients who had CABG

169 Acute medical and neurological complications in stroke patients are analys

170 tudy to investigate hospital admissions from neurological complications in the 28 days after a first

171 izes the current evidence on ZIKV-associated neurological complications in the adults.

172 mmary, although we find an increased risk of neurological complications in those who received COVID-1

173 The higher incidence of perioperative neurological complications in women cannot be explained

174 s associated with gastroenteritis and severe neurological complications in young children, the immuno

175 Management of neurological complications includes symptomatic treatmen

176 luenza A (H1N1) has been recognized to cause neurological complications including seizures and enceph

177 COVID-19 is associated with neurological complications including stroke, delirium an

178 incontinence, (2) other previously reported neurological complications (including anosmia, ataxia, e

179 Down syndrome (DS) is associated with neurological complications, including cognitive deficits

180 igen-targeting CAR T cell therapies, delayed neurological complications, including cranial nerve pals

181 lar complications (0.81; 95% CI, 0.81-0.82); neurological complications, including delirium (0.87; 95

182 classified based on their susceptibility to neurological complications, including life-threatening o

183 usion requirement, postoperative hemoglobin, neurological complications, intensive care unit and hosp

184 postoperative hemoglobin, chest infections, neurological complications, intensive care unit and hosp

185 Recent investigations have emphasized neurological complications, introducing the possibility

186 holds potential therapeutic implications for neurological complications involving brain dystrophin de

187 of life are associated with a risk of severe neurological complications later in life.

188 e that, while usually mild, can cause severe neurological complications, leading to hundreds of death

189 Neurological complications, mainly seizures and altered

190 rointestinal complications (n = 58 [40.8%]), neurological complications (n = 22 [15.5%]), and traumat

191 with SAE (n = 18), with vaccination without neurological complications (n = 43), and without vaccina

192 Neurological complications (NC) after hematopoietic stem

193 t, liver, thymus, and lung are GVHD targets, neurological complications (NC) have also been reported

194 f Zika virus (ZIKV) and its association with neurological complications necessitates studies on the m

195 There were no acute neurological complications, no thromboembolic events, an

196 Neurological complications occur frequently in solid org

197 Neurological complications occurred after a median of 5.

198 The primary outcome was a neurological complication occurring at the point of deat

199 berculosis load may be a useful predictor of neurological complications occurring during TBM treatmen

200 dent risk factors for measles mortality were neurological complications (odds ratio [OR], 12.8; 95% c

201 eral neuropathy (CIPN) is the most prevalent neurological complication of chemotherapy for cancer, an

202 opathy (HIV-SN) is currently the most common neurological complication of chronic HIV infection and c

203 ON: Myelopathy is considered the most common neurological complication of copper deficiency.

204 d sensory neuropathy remains the most common neurological complication of HIV infection and is charac

205 d sensory neuropathy (SN) is the most common neurological complication of HIV infection in the curren

206 Peripheral neuropathy is the most frequent neurological complication of HIV infection, affecting mo

207 nsory neuropathy (HIV-SN) is the most common neurological complication of HIV infection.

208 inful HIV-associated sensory neuropathy is a neurological complication of HIV infection.

209 Peripheral neuropathy is the most common neurological complication of HIV-1 infection, affecting

210 1 (HIV-1) infection, 20-30% will develop the neurological complication of HIV-associated dementia (HA

211 nsory polyneuropathies are the most frequent neurological complication of human immunodeficiency viru

212 troviral toxic neuropathy is the most common neurological complication of human immunodeficiency viru

213 Cerebral malaria (CM) is a neurological complication of infection with Plasmodium f

214 Hepatic encephalopathy is a serious neurological complication of liver failure.

215 encephalitis (SSPE) is a rare but fatal late neurological complication of measles, caused by persiste

216 s infected with NotPolyA experienced reduced neurological complications of acute infection relative t

217 VD) is among the most common and most feared neurological complications of AIDS.

218 The neurological complications of Behcet's syndrome have not

219 jury is known to predispose its sufferers to neurological complications of concurrent poliovirus infe

220 Overall, neurological complications of COVID-19 are associated wi

221 To understand neurological complications of COVID-19 better both acute

222 l (HPA) axis function also contribute to the neurological complications of diabetes phenotypes.

223 mplicated in the development of vascular and neurological complications of diabetes.

224 diverse cardiovascular, renal, retinal, and neurological complications of diabetes.

225 ther they are involved in the development of neurological complications of falciparum malaria.

226 l-characterized rhesus macaque models of the neurological complications of HIV infection (neuroAIDS),

227 Neurological complications of HIV infection cause consid

228 This may affect the development of neurological complications of HIV infection.

229 The neurological complications of HIV or NeuroHIV, represent

230 A key protein associated with the neurological complications of HIV, gp120, forms part of

231 Neurological complications of Lassa fever (LF) are assoc

232 Although neurological complications of SARS-CoV-2 infection are r

233 We approach the problem of neurological complications of systemic cancer as would a

234 Neurological complications of systemic cancer-those aris

235 association with the serious post-infection neurological complications of the Miller-Fisher and Guil

236 olved in the etiology and progression of the neurological complications of these disorders.

237 Neurological complications of tuberculous meningitis (TB

238 er understanding of the systemic effects and neurological complications of viral infection.

239 endemic regions or for the treatment of the neurological complications of Zika virus infection.

240 nes against EV-A71, a disease causing severe neurological complications or even death, are currently

241 vere infection with EV71 can lead to various neurological complications or fatal diseases.

242 thasone (n = 2,580) was associated with less neurological complications (OR = 0.78, 95% CI = 0.62-0.9

243 6) were associated with a lower frequency of neurological complications: OR = 0.76 (95% confidence in

244 Our patients had fewer pretreatment neurological complications (PFP, pareses) than reported

245 been associated with fetal abnormalities and neurological complications, prompting global concern.

246 he >30 million HIV-infected subjects develop neurological complications ranging from mild symptoms to

247 The neurological complication rate was 4.9% (1.5% major, 3.4

248 rrence of respiratory, cardiac, allergic, or neurological complications requiring immediate intervent

249 complications (RR=1.73, 95% CI: 1.35-2.23), neurological complications (RR=1.38, 95% CI: 1.01-1.88),

250 le cell disease, 29 asymptomatic and 47 with neurological complications (seizures, stroke, transient

251 Additionally, convalescent participants with neurological complications show elevated GFAP and NfL, u

252 stations range from respiratory illnesses to neurological complications such as acute flaccid myeliti

253 In severe cases, mumps can lead to neurological complications such as aseptic meningitis an

254 The neurological complications such as depression, anxiety,

255 Despite the declining incidence of severe neurological complications such as HIV encephalopathy, h

256 CNS) of HIV patients, likely contributing to neurological complications such as neurocognitive disord

257 abuse increases the risk of life-threatening neurological complications such as strokes and seizures.

258 sonal epidemics that include cases of severe neurological complications, such as acute flaccid paraly

259 Neurological complications, such as brain oedema or haem

260 ivation but in rare cases can lead to severe neurological complications, such as encephalitis.

261 d during SIRS, and sepsis and the consequent neurological complications, such as encephalopathy, are

262 eak in South America, substantial numbers of neurological complications, such as Guillain-Barre syndr

263 These include neurological complications, such as HIV-associated neuro

264 pproximately 1 in 150 cases develops serious neurological complications, such as meningitis or enceph

265 entral nervous system (CNS) and cause severe neurological complications, such as MIBE and SSPE.

266 ng cardiac surgery are more likely to suffer neurological complications than men and whether these co

267 r HIV viral loads and experience more severe neurological complications than non-users, the direct im

268 d experienced greater infectious, renal, and neurological complications than those with a single epis

269 ppurative swelling of the parotid glands and neurological complications that can result in aseptic me

270 2 (SARS-CoV-2) infection are associated with neurological complications that may be linked to direct

271 s on the management of CAR T-cell associated neurological complications that occur after treatment wi

272 ntly developed mouse models mimic the severe neurological complications that occur in a small percent

273 In children, seizure was the only neurological complication to occur more frequently in IC

274 e number of patients with cardiopulmonary or neurological complications was 82,486 (case-severity rat

275 Prevalence of neurological complications was comparable for both group

276 All in-hospital neurological complications were associated with increase

277 In both groups, neurological complications were associated with increase

278 al function, gastrointestinal disorders, and neurological complications were commonly reported in bot

279 ral developmental phase of carotid stenting, neurological complications were highly dependent on pati

280 Pretransplant neurological complications were prevalent, and severe po

281 Overall rates of mortality and neurological complications were relatively low but signi

282 No neurological complications were reported at the follow-u

283 No adverse neurological complications were reported, although one p

284 In adults, the most frequent in-hospital neurological complications were stroke (1.5%), seizure (

285 Neurological complications were uncommon overall (6.9%),

286 Independent risk factors associated with all neurological complications were vegetation size >/=3 cm

287 he current management of other non-classical neurological complications, which frequently develop aft

288 ate that there is a correlation between ZIKV neurological complications with higher Gas6 levels and t

289 Enterovirus 71 (EV71) causes a spectrum of neurological complications with significant morbidity an

290 reat, responsible for severe respiratory and neurological complications, with no FDA-approved antivir

291 case definitions of SARS-CoV2 infection and neurological complications, with standardised forms for

292 Neurological complications worsen outcomes in COVID-19.

293 of the factors that predispose a patient to neurological complications would facilitate further refi